Nephrology Doctors in Mobile, AL Accepting Medicare

8 Nephrology doctors found. Showing 1 - 8

Sabrina G. Bessette, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2451 University Hospital Drive, Mastin 102, Mobile, AL 36617 Phone: 251-470-5890    Fax: 251-471-7925

Errol D. Crook, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2451 Fillingim St, Mastin Bldg., Mobile, AL 36617 Phone: 251-470-5890    Fax: 251-471-7925

Dr. Richard Sellors Meador Jr., M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 124a South University Blvd., Mobile, AL 36608 Phone: 251-343-5004    Fax: 251-343-5136

Andrew Felis, DO Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 124 S University Blvd, Mobile, AL 36608 Phone: 251-343-5004    Fax: 251-343-8383

Emad Al Jaber, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2451 Fillingim St # 102, Mobile, AL 36617 Phone: 251-470-5890    Fax: 251-471-7925

Wanda G. Kirkpatrick, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2451 Fillingim St, Mastin Bldg, Mobile, AL 36617 Phone: 251-470-5890    Fax: 251-471-7925

Roy Michael Culpepper, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 2451 Fillingim St, Mastin Bldg., Mobile, AL 36617 Phone: 251-470-5890    Fax: 251-471-7925

Gregory Rutecki, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2451 Fillingim St, Masting Bldg., Mobile, AL 36617 Phone: 251-470-5890    Fax: 251-471-7925

News Archive

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.

Loss of dietary protein from food as carbon dioxide emissions fail to fall - warn researchers

According to researchers at the Harvard T.H. Chan School of Public Health, if the present rates of carbon dioxide emissions do not stop, people in around 18 countries worldwide may face a loss of around 5% of the protein they obtain from their diet by 2015. This is due to the reduction in the nutrient values of crops such as rice, wheat and other staples. This would put an additional 150 million people at risk of dietary protein deficiency. This is the first study that actually quantifies the actual dietary health risk posed by greenhouse gas emissions.

Study: COPD linked with increased risk of developing cerebral microbleeds

Chronic obstructive pulmonary disease is associated with an increased risk of developing cerebral microbleeds, according to a new study from researchers in the Netherlands. Cerebral microbleeds are a marker of cerebral small vessel disease, an important cause of age-related disability and cognitive decline.

Seeds of violence may be planted before a child is born: Research

It's hard to think of a baby being violent or destructive, but the seeds of violence may be planted before a child is born, according to research at the University of Pennsylvania School of Nursing.

Read more Medical News

› Verified 1 days ago